Although our studies indicated that exosomes carrying miRNAs targeting HER2 did not affect HER2-negative cells, it was nevertheless desirable to increase the uptake of exosomes carrying HER2-targeting miRNAs by HER2-positive tumor cells. The gene discussed is ERBB2; the disease is neoplasm.